Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
   FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
   
  
  
  January 31, 2024
  From Benzinga
 
   'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challenges
   
  
  
  January 30, 2024
  From Benzinga
 
   Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
   
  
  
  January 27, 2024
  From Benzinga
 
   Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
   
  
  
  January 26, 2024
  From Benzinga
 
   Podcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy Frontiers
   
  January 25, 2024
  Tickers 
   IXHL
  
  
  From Benzinga
 
   New Study Reveals Suggestibility's Role In Antidepressant Effects Of Psilocybin Therapy
   
  January 25, 2024
  Tickers 
   CMPS
  
  
  From Benzinga
 
   Australian Psychiatrists Provide First Psychedelic-Assisted Medical Treatments In 50 Years
   
  
  January 24, 2024
  From Benzinga
 From Benzinga
 
   Psychedelics Reform Update: Alaska's Task Force, West Virginia, Arizona's Firefighters, New Jersey' & More
   
  January 20, 2024
  Tickers 
   NEWS
  
  
  From Benzinga
 
   Numinus Wellness Continues Tight Expense Management With Strategic Reviews Underway
   
  
  
  January 18, 2024
  From Benzinga
 
   Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
   
  
  
  January 15, 2024
  From Benzinga
 
   MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
   
  
  
  January 11, 2024
  From Benzinga
 From Benzinga
 
   Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
   
  
  
  January 09, 2024
  From Benzinga
 
   Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
   
  
  
  January 08, 2024
  From Benzinga
 
   BREAKING: Ibogaine Therapy Show Promising Outcomes For Veterans With Trauma Brain Injury
   
  January 05, 2024
  Tickers 
   NEWS
  
  
  From Benzinga
 
   Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment
   
  
  
  January 04, 2024
  From Benzinga
 From Benzinga
 
   AMA's Reimbursement Codes For Psychedelic-Assisted Therapies Take Effect: Here's What To Expect
   
  
  
  January 03, 2024
  From Benzinga
 
   Kentucky's Promising Opioid Addiction Treatment Initiative Stalls As New AG Ousts Leading Advocate
   
  December 29, 2023
  Tickers 
   NEWS
  
  
  From Benzinga
 
   Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
   
  
  
  December 22, 2023
  From Benzinga
 
   Do Psychedelic Treatments Always Require Psychotherapy? Well, We Need To Look 'Beyond Reductionism'
   
  December 19, 2023
  Tickers 
   CMPS
  
  
  From Benzinga
 
   Psychedelics Legalization & 2024 Election: Robert F. Kennedy Jr. Confirms Support In New Interview
   
  
  December 18, 2023
  From Benzinga
 
   Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
   
  
  
  December 18, 2023
  From Benzinga
 
   Biden To Decide On Psychedelic Therapy Bill, Trial Funds For Active Servicemembers
   
  
  December 14, 2023
  From Benzinga
 
   State-Regulated Psychedelics 'On A Collision Course' With FDA, Says Harvard Law Expert
   
  
  December 12, 2023
  From Benzinga
 
   Merger Alert: Tryp Therapeutics Signs With Australian Drug Delivery Innovator, Details Here
   
  
  December 11, 2023
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.